MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma
- PMID: 9197523
- PMCID: PMC5921430
- DOI: 10.1111/j.1349-7006.1997.tb00386.x
MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma
Abstract
The MAD (mothers against decapentaplegic)-related genes, Smad2 (former name MADR2 or JV18-1) and Smad4 (former name DPC4), have been identified on chromosome 18q21.1. We analyzed 30 primary esophageal squamous cell carcinomas (ESCC) and 7 cell lines derived from ESCC for intragenic mutations and loss of heterozygosity (LOH) of the Smad2 and Smad4 genes. LOH was detected in 5 of 14 (35%) informative cases. However, no mutations in either gene were detected in either the primary carcinomas or the cell lines, and only a G-to-A base transition within the 3'-untranslated region of the Smad4 gene was observed in a carcinoma. There were no homozygous deletions in either of the genes in the cell lines. MAD-related genes on chromosome 18q21.1 are altered infrequently in ESCC.
References
-
- ) Filmus , J. and Kerbel , R. S.Development of resistance mechanisms to the growth‐inhibitory effects of transforming growth factor‐β during tumor progression , Curr. Opin. Oncol. , 5 , 123 – 129 ( 1993. ). - PubMed
-
- ) Roberts , A. B. and Sporn , M. B.Physiological actions and clinical applications of transforming growth factor‐β (TGFβ) . Growth Factors , 8 , 1 – 9 ( 1993. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous